Abstract. Periodontal ligament-associated protein-1 (PLAP-1/ asporin) is a special marker in periodontal ligament tissue. It is an important regulator of osteogenic differentiation of periodontal ligament cells (PDLCs). This marker is also a prerequisite for periodontal ligament development and mineralization in maintaining homeostasis of the periodontium. However, the molecular mechanisms of the regulation of PLAP-1 expression at the post-transcriptional level remain unknown. By contrast, microRNAs (miRNAs) provide an additional level of regulation beyond that of transcription factors via regulation of the post-transcriptional control of gene expression. This study was designed to analyze miRNA differential expression patterns of PDLCs at various osteoblastic differentiation stages and to determine the contribution of miRNAs in the regulation of PLAP-1 expression during osteoblast differentiation. Bioinformatic analysis was performed to predict miRNAs that potentially regulate the gene expression of PLAP-1. Dual luciferase reporter assay and qRT-PCR were performed to confirm the effects of these miRNAs on PLAP-1 gene expression. Our results indicated that mir-101 and mir-21 target PLAP-1 to regulate its expression during osteogenic differentiation of PDLCs.
Introduction
Periodontal ligament (PDL), the most important tissue influencing the lifespan of the human tooth, is composed of heterogeneous cell populations including osteoblasts, which have osteogenic differentiation potential (1) (2) (3) . Osteogenesis of periodontal ligament cells (PDLCs) is part of an important process of cytodifferentiation and mineralization to form mineralized tissue cells (4) . Osteoblast differentiation results in the expression of tissue-specific gene products that form and regulate the structure of the mineralized PDL extracellular matrix (5) .
Periodontal ligament associated protein-1 (PLAP-1/ asporin), a specific marker of the PDL, is an important negative regulator of osteogenic differentiation in maintaining the homeostasis of periodontium (6) (7) (8) . PLAP-1 was first identified as a novel member of the small leucine-rich repeat proteoglycan (SLRP) family and confirmed to be expressed specifically and predominantly in the PDL (9-10). PLAP-1 was found to be closely associated with the process of cytodifferentiation of PDL cells (11) . Therefore, the relative expression level of PLAP-1 may be regarded as a specific marker for the osteogenic differentiation of PDLCs.
Moreover, PLAP-1 was not only expressed specifically in the PDL of an erupted tooth but also in the dental follicle, which is the progenitor tissue of the PDL during tooth development (8) . This result suggests that PLAP-1 may be involved in PDL development and cytodifferentiation (11) .
Furthermore, it is important to understand the processes that regulate the mineralization of PDLCs. Previous studies showed that the osteogenesis of PDLCs, a complex process in which multiple signaling pathways are involved, is regulated by numerous growth and transcription factors (12) (13) (14) . However, the mechanism of PLAP-1 expression regulation is not clear, particularly at the post-transcriptional level.
MicroRNAs (miRNAs) provide an additional level of gene regulation beyond that of transcription factors. miRNAs are a class of small non-coding RNA molecules that regulate gene expression post-transcriptionally in eukaryotic cells (15) (16) (17) (18) . miRNAs are approximately 22 nucleotide single-stranded RNAs that silence gene expression by binding to target mRNAs. Mature miRNAs target the 3' untranslated regions (3'UTR) of genes by complementary base-pair binding (19) (20) . We hypothesized that certain miRNAs may be able to regulate PLAP-1 gene expression and lead to differentiation of PDLCs.
Therefore, the aim of this study was to determine which miRNAs are responsible for regulating PLAP-1 expression during osteoblast differentiation. We analyzed miRNA differential expression patterns of PDLCs at various osteoblastic differentiation stages. 
Materials and methods
Cell culture of PDLCs. Primary human PDLCs were isolated from explanted healthy PDL in the middle third of the periodontal membrane root of impacted third molars (21) . The cells were cultured in a growth medium containing Dulbecco's modified Eagle's medium (DMEM) (Gibco, Grand Island, NY, USA) with 10% fetal bovine serum, 1% L-glutamine, 10,000 IU/ml penicillin G, 100,000 mg/ml streptomycin sulfate and 25 mg/ml amphotericin B at 37˚C with 5% CO 2 in a 24-well plate. Cells from the second passage were used for all experiments. To activate differentiation and mineralization, PDLCs were cultured in a mineralizing medium containing growth medium, 50 mg/ml ascorbic acid, 10 mM β-glycerophosphate and 0.01 mM dexamethasone (Sigma, St. Louis, MO, USA) (1-3). 293T cells were grown in DMEM supplemented with 10% fetal bovine serum.
Mineralization staining. Mineralization of cultured PDLCs was determined using Alizarin Red (AR) staining. Following 14 days of culture in mineralizing medium, the PDLC layer was washed with phosphate-buffered saline (PBS) twice and fixed in 10% formaldehyde (Sigma-Aldrich) at room temperature for 20 min. The layer was then washed in duplicate with excess dH 2 O prior to the addition of 1 ml of 40 mM AR (pH 4.1). The plates were incubated at room temperature for 30 min under gentle agitation. Following removal of the unincorporated dye, the plates were washed twice with PBS and visualized using inverted microscopy (Nikon).
Reverse transcription-PCR. Total RNA was prepared from the mineralized PDLC culture of days 7 and 14. First-strand cDNA synthesis and PCR processes were performed according to the manufacturer's instructions. The primer sets for PCR in this study are summarized in Table I . The reaction conditions were 94˚C for 5 min, then 30 cycles of amplification; each cycle consisted of 94˚C for 45 sec, 51˚C for 45 sec, and 72˚C for 1 min. The extension time was prolonged to 10 min in the last cycle.
Bioinformatic analyses. Bioinformatic scans of the 3'UTR of PLAP-1 were conducted using four web-based miRNA target prediction programs: miRanda, PICTAR 4, PITA and TargetScan (22) (23) (24) (25) (26) (27) (28) (29) (30) . miRNAs were selected based on their targeted prediction by the four programs, conservation of the binding region and the strength of the predicted interaction.
Dual luciferase reporter assay. The psiCHECK™-2 luciferase vector (Promega, Madison, WI, USA) was used for the dual luciferase assays. The 3'UTR of PLAP-1 was inserted at the XhoI/NotI sites. Fragments of PLAP-1 3'UTR were obtained by PCR using PLAP-1 cDNA as a template. The PCR products were ligated into the psiCHECK-2 vector to construct the plasmid psiPLAP-1 (Promega). Luciferase assays were performed using the Dual-luciferase reporter assay system (E1910), according to the manufacturer's instructions (Promega). 293T cells were co-transfected with the plasmid psiPLAP-1 (0.5 µg/well) and miRNA (20 µM) using Lipofectamine 2000 (Invitrogen). Forty-eight hours after transfection, the medium was removed and the cells were washed twice using PBS. Passive lysis buffer (PLB) (100 µl) was added to each well. Cell lysates were collected and luciferase activity was measured by a GloMax™ 20/20 luminometer (Promega). The luciferase data were expressed Table I . Oligonucleotides used in this study.
Primer name
Sequence-specific forward primer
miRNA-R is the universal reverse primer used in conjunction with a sequence-specific forward primer for hsa-mir21 and hsa-mir101. RT, step-loop primer; F, forward; R, reverse.
as a ratio of Renilla luciferase (RL) to firefly luciferase (FL) to normalize for transfection variability between samples. Luciferase experiments were repeated in triplicate.
qRT-PCR. PDLCs were cultured in mineralizing medium to induce osteogenic differentiation. Cells were harvested for isolation of RNA at 7, 10, 14, 21 or 28 days of culture to detect changes in the gene expression of PLAP-1, OCN and two miRNAs. Cells cultured in growth medium served as controls. RNA was isolated from the cells using TRIzol (Invitrogen, Grand Island, NY, USA) according to the manufacturer's instructions. For qPCR, 0.1 µg of RNA per reaction was used with the Quantitech SYBR-Green RT-PCR kit and primers specific for PLAP-1 or OCN. To quantify miRNA expression, total RNA was reverse-transcribed for qPCR using the stem-loop method (31) (32) (33) (34) . Based on the stem-loop feature of the miRNA and cross-species comparison, a number of computational algorithms have been developed to predict miRNAs from the genome. The resulting cDNA was subjected to qPCR using the universal reverse primer in conjunction with a sequence-specific forward primer of hsa-mir21 and hsa-mir101. Each sample was performed in triplicate, and the results were normalized to 18S rRNA (for PLAP-1) or U6 (for miRNA analysis) (Table I) . Results were expressed as fold changes.
Statistical analysis. Data were presented as the mean ± SD (n=3). Statistical analysis was performed using the Student's t-test. P<0.05 was considered to indicate a statistically significant difference.
Results
Characteristics of PDLCs. Dexamethasone (Dex) and/ or β-glycerophosphate (β-GP) have been shown to induce osteoblast features of PDLCs (1-3). Cultured PDLCs were spindle-shaped in appearance (Fig. 1A) . These PDLCs were fibroblast-like cells and were grown to a near-confluent state. After 7 days, mineralized nodules formed and became more condensed. AR staining of mineralized nodules in representative cell cultures is shown in Fig. 1B . Our results showed that two specific markers for the osteogenic differentiation of PDLCs, osteocalcin (OCN) and PLAP-1, were expressed on day 7 and thereafter ( Fig. 1C) . Previous studies and our data confirmed that PDLCs were a suitable model for our study.
Bioinformatic analyses identified candidate miRNAs that potentially regulate PLAP-1.
Based on the stem-loop feature of the miRNA and cross-species comparison, a number of compu- hsa-mir-21 hsa-mir-21 hsa-mir-21 hsa-mir-26a-2 hsa-mir-26a-2 hsa-mir-26a-2 hsa-mir-26a-2 hsa-mir-26b hsa-mir-26b hsa-mir-26b hsa-mir-26b
Four miRNA target search algorithms (TargetScan, miRanda, PICTAR 4 and PITA) were utilized to generate a list of candidate miRNAs that potentially bind to the PLAP-1 3'UTR. The miRNAs were predicted using the four programs. tational algorithms have been developed to predict miRNAs from the genome. Bioinformatic scans are the in silicon standard for assembling a list of candidate miRNAs predicted to target the 3'UTR of a given RNA (22-23,26-27). Four programs (miRanda, PICTAR 4, PITA and TargetScan) were employed to generate a list of potential miRNAs with a high probability of binding to the 3'UTR of PLAP-1 (Table II) . To narrow down this list and increase the probability of identifying miRNAs that are capable of regulating PLAP-1, we tested five miRNAs that were identified by all of the four programs.
The luciferase reporter assay showed that mir101 and mir21 regulated PLAP-1. To test whether candidate miRNAs are capable of interacting with the 3'UTR sequence of PLAP-1, luciferase reporter assays were performed. The 3'UTR of PLAP-1 was inserted into the psiCHECK-2 vector and transiently transfected into 293T cells. This construct allowed us to rapidly and quantitatively evaluate miRNA effects on the 3'UTR of PLAP-1. The PLAP-1 3'UTR fragment inserted into the psiCHECK-2 luciferase vector is shown in Fig. 2 .
The relative luciferase activity in 293T cells transfected with Fig. 3. mir101 and mir21 (Fig. 4) significantly (P<0.01, P<0.05) reduced luciferase activity when compared to the negative scrambled miRNA and the luciferase vector alone, whereas mir144, mir26a and mir26b (Fig. 5) did not reduce luciferase activity. Furthermore, we mutated the binding site of PLAP-1 3'UTR to create the constructs mutpsiPLAP-21 and mutpsiPLAP-101. As shown in Fig. 6 , mir101 and mir21 were no longer able to reduce luciferase activity. These data suggest that mir101 and mir21 targeted to PLAP-1 to regulate its expression.
Overexpression of mir101 or mir21 reduced the PLAP-1 expression level. To confirm the reporter assay results, mir101 or mir21 were overexpressed and the mRNA level of PLAP-1 was measured. Our qPCR data showed that the overexpression (Fig. 7A) . Overexpression of mir21 (Fig. 7B ) and mir101 ( Fig. 7C) was confirmed by qPCR. These data confirmed that mir101 and mir21 regulated PLAP-1 expression. (35) (36) . In this study, the expression of PLAP-1 was low prior to day 7 and this expression increased by day 10. After day 14, PLAP-1 was markedly expressed (Fig. 8A) . As a regulator of PLAP-1 gene expression, the expression level of the two miRNAs was inversely correlated with that of PLAP-1 (Fig. 8) .
Discussion
In this study, we described the pattern of PLAP-1/asporin gene expression at various stages of the osteogenic differentiation of PDLCs. Our data have demonstrated that the transcription of PLAP-1 was upregulated during the process of cytodifferentiation of PDL cells into mineralized-tissue-forming cells (Fig. 8A) , which is consistent with previous studies (6) . Moreover, we established an expression profile of miRNAs targeting the PLAP-1 gene in human PDLCs and identified the differential expression patterns of miRNAs closely associated with the process of osteogenic differentiation of PDLCs for the first time. This study indicates that there is more than one miRNA directly associated with PLAP-1 during the process of osteogenic differentiation. Our data showed that mir101 and mir21 regulated PLAP-1 expression directly. These observations suggest that the expression of PLAP-1 during osteogenesis was controlled not only by differentially expressed transcription factors and growth factors, but also by differentially expressed miRNAs. This is the first study to explore the effects of miRNAs on PDLC differentiation and PLAP-1 expression. The results have shown that the expression level of PLAP-1 was inversely correlated with that of mir21 and mir101 during the osteogenic differentiation of PDLCs. This finding indicates that mir21 and mir101 may be involved in the osteogenic differentiation of PDLCs. Our aim was not only to identify miRNAs that regulate the PLAP-1 of PDLCs, but also to predict a subset of miRNAs that can be regulated during the differentiation of PDLCs cells and result in abnormal osteogenesis formation. Further investigation in this direction is required.
